Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SwabTek is a private U.S. company that develops and sells dry, paper-based presumptive field test kits for narcotics, explosives, and related threat-detection applications. Its products are designed for rapid on-site screening by law enforcement, security personnel, schools, corrections facilities, transportation security teams, and some consumer/home users. The company emphasizes safer handling than legacy liquid-reagent kits by using dry reagents embedded on paper-based test formats. SwabTek markets individual tests for substances such as fentanyl, cannabis, cocaine, heroin, and amphetamines, as well as broader narcotics screens, gunshot residue tests, and explosive detection kits. The business appears to be commercially focused rather than drug-development oriented, with revenue derived from selling test kits and related screening solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SwabTek.